PORPHOBILINOGEN SYNTHASE FAMILY

胆色素原合酶家族

基本信息

  • 批准号:
    6518032
  • 负责人:
  • 金额:
    $ 35.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-04-01 至 2004-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from Applicant's Abstract) The porphobilinogen synthases (PBGS's) are ancient proteins, essential to nearly all cellular organisms. They catalyze the first common step in tetrapyrrole biosynthesis (i.e., porphyrin, chlorophyll, vitamin B12, etc.), which is the condensation of two molecules of 5-aminolevulinic acid to form porphobilinogen. To date, only one reaction intermediate is known for this complex reaction. All PBGS's are metalloenzymes and metal ion usage has suffered a unique phylogenetic switch between Zn(II) and Mg(II). Human PBGS is the primary target for lead poisoning and the less frequent of two alleles is reported to predispose humans toward this environmental disease. The proposed studies address various aspects of the PBGS's. The first specific aim uses a novel "designer gene" approach to produce and purify 100 mg quantities of human and pea PBGS because human PBGS uses Zn(II) and pea PBGS uses Mg(II). The second aim is to characterize the PBGS derived from two common human alleles and determine the molecular basis for their apparent Pb(II)-related differences. This aim includes a thorough kinetic and biochemical characterization of the human proteins, including 13C NMR and collaborative EXAFS and Raman spectroscopies and X-ray crystallography. The Raman data are complementary to the 13C NMR data on active site ligands. The third aim uses mutagenesis in conjunction with kinetics, metal and substrate binding studies, and magnetic resonance techniques, plus collaborative techniques to probe structure/function relationships in PBGS. The mutations will allow us to characterize the yet unknown intermediates in the PBGS-catalyzed reaction. Some mutations probe individual functions of the two active site Zn(II) of human PBGS and others probe the structural basis for half-sites reactivity in these homo-octameric proteins. The fourth aim focuses on the intriguing phylogenetic switch between the catalytically essential Zn(II) vs. Mg(II). Studies are directed at pea PBGS and also probe an allosteric Mg(II), absent in mammalian PBGS but present in plant and many microbial PBGS. The sum of the proposed studies is expected to yield new and important information on the mechanism of lead poisoning, on the intermediate in the PBGS catalyzed reaction, on the possible roles of both Zn(II) and Mg(II) in enzyme catalysis, on the structural basis for half sites reactivity, and on the phylogenetic differences between PBGSs. Because PBGS is an essential enzyme with distinct variations between species, we envision that a thorough understanding of the phylogenetic differences will form the basis for the rational design of a new class of organism-specific drugs.
描述:(改编自申请人摘要)卟啉胆素原合成酶

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EILEEN K JAFFE其他文献

EILEEN K JAFFE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EILEEN K JAFFE', 18)}}的其他基金

A New View of PAH Allostery - Correlation with Disease-Associated Alleles
PAH 变构的新观点 - 与疾病相关等位基因的相关性
  • 批准号:
    9981023
  • 财政年份:
    2016
  • 资助金额:
    $ 35.45万
  • 项目类别:
A New View of PAH Allostery - Correlation with Disease-Associated Alleles
PAH 变构的新观点 - 与疾病相关等位基因的相关性
  • 批准号:
    9547552
  • 财政年份:
    2016
  • 资助金额:
    $ 35.45万
  • 项目类别:
A New View of PAH Allostery - Correlation with Disease-Associated Alleles
PAH 变构的新观点 - 与疾病相关等位基因的相关性
  • 批准号:
    9350419
  • 财政年份:
    2016
  • 资助金额:
    $ 35.45万
  • 项目类别:
Low Activity Oligomers of Porphobilinogen Synthase as Antibiotic Targets
作为抗生素靶标的胆色素原合酶的低活性寡聚物
  • 批准号:
    8069778
  • 财政年份:
    2009
  • 资助金额:
    $ 35.45万
  • 项目类别:
Low Activity Oligomers of Porphobilinogen Synthase as Antibiotic Targets
作为抗生素靶标的胆色素原合酶的低活性寡聚物
  • 批准号:
    7935543
  • 财政年份:
    2009
  • 资助金额:
    $ 35.45万
  • 项目类别:
The Porphobilinogen Synthase Family
胆色素原合酶家族
  • 批准号:
    7909702
  • 财政年份:
    2009
  • 资助金额:
    $ 35.45万
  • 项目类别:
Hexameric PBGS as a Bioterrorism Defense
六聚 PBGS 作为生物恐怖主义防御手段
  • 批准号:
    7036579
  • 财政年份:
    2005
  • 资助金额:
    $ 35.45万
  • 项目类别:
Hexameric PBGS as a Bioterrorism Defense
六聚 PBGS 作为生物恐怖主义防御手段
  • 批准号:
    6853243
  • 财政年份:
    2005
  • 资助金额:
    $ 35.45万
  • 项目类别:
PORPHOBILINOGEN SYNTHASE FAMILY
胆色素原合酶家族
  • 批准号:
    6178262
  • 财政年份:
    1991
  • 资助金额:
    $ 35.45万
  • 项目类别:
The Porphobilinogen Synthase Family
胆色素原合酶家族
  • 批准号:
    7194203
  • 财政年份:
    1991
  • 资助金额:
    $ 35.45万
  • 项目类别:

相似海外基金

Synthesis, Characterization and Catalytic Activity of Metal Complexes of New Schiff Bases Derived from Biphenyl-diamine
联苯二胺新型席夫碱金属配合物的合成、表征及催化活性
  • 批准号:
    320823118
  • 财政年份:
    2016
  • 资助金额:
    $ 35.45万
  • 项目类别:
    Research Grants
MYELOPEROXIDASE-DERIVED 2-CHLOROHEXADECANAL FORMS SCHIFF BASES WITH
髓过氧化物酶衍生的 2-氯十六醛形成席夫碱
  • 批准号:
    7721513
  • 财政年份:
    2008
  • 资助金额:
    $ 35.45万
  • 项目类别:
Studies on elucidation of isomerization reaction of Schiff bases crystals and construction of novel proton flux. supramolecular systems
席夫碱晶体异构化反应的阐明及新型质子通量的构建研究。
  • 批准号:
    14540498
  • 财政年份:
    2002
  • 资助金额:
    $ 35.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
METAL MEDIATED SCHIFF BASES FOR MEDICINAL AGENT SYNTHESIS
用于药物合成的金属介导席夫碱
  • 批准号:
    6664015
  • 财政年份:
    2002
  • 资助金额:
    $ 35.45万
  • 项目类别:
METAL MEDIATED SCHIFF BASES FOR MEDICINAL AGENT SYNTHESIS
用于药物合成的金属介导席夫碱
  • 批准号:
    6491831
  • 财政年份:
    2001
  • 资助金额:
    $ 35.45万
  • 项目类别:
SYNTHESIS & ANTIMYCOBACTERIAL ACTIVITY OF NOVEL SCHIFF BASES
合成
  • 批准号:
    6478944
  • 财政年份:
    2000
  • 资助金额:
    $ 35.45万
  • 项目类别:
SYNTHESIS & ANTIMYCOBACTERIAL ACTIVITY OF NOVEL SCHIFF BASES
合成
  • 批准号:
    6345220
  • 财政年份:
    2000
  • 资助金额:
    $ 35.45万
  • 项目类别:
METAL MEDIATED SCHIFF BASES FOR MEDICINAL AGENT SYNTHESIS
用于药物合成的金属介导席夫碱
  • 批准号:
    6353006
  • 财政年份:
    2000
  • 资助金额:
    $ 35.45万
  • 项目类别:
METAL MEDIATED SCHIFF BASES FOR MEDICINAL AGENT SYNTHESIS
用于药物合成的金属介导席夫碱
  • 批准号:
    6347540
  • 财政年份:
    2000
  • 资助金额:
    $ 35.45万
  • 项目类别:
METAL MEDIATED SCHIFF BASES FOR MEDICINAL AGENT SYNTHESIS
用于药物合成的金属介导席夫碱
  • 批准号:
    6204176
  • 财政年份:
    1999
  • 资助金额:
    $ 35.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了